Tempus AI, Inc. (NASDAQ:TEM) Receives Consensus Recommendation of “Buy” from Analysts

Tempus AI, Inc. (NASDAQ:TEM) has earned an average recommendation of “Buy” from the nine ratings firms that are covering the firm, Marketbeat.com reports. Nine research analysts have rated the stock with a buy rating. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is $46.25.

A number of analysts have commented on TEM shares. Longbow Research started coverage on shares of Tempus AI in a report on Tuesday, July 9th. They issued a “buy” rating and a $48.00 price objective for the company. William Blair initiated coverage on Tempus AI in a research note on Tuesday, July 9th. They set an “outperform” rating on the stock. TD Cowen assumed coverage on shares of Tempus AI in a research report on Tuesday, July 9th. They set a “buy” rating and a $50.00 price target on the stock. JPMorgan Chase & Co. raised their price objective on shares of Tempus AI from $42.00 to $47.00 and gave the stock an “overweight” rating in a research report on Wednesday. Finally, Loop Capital began coverage on shares of Tempus AI in a report on Tuesday, July 9th. They issued a “buy” rating and a $48.00 target price on the stock.

Institutional Trading of Tempus AI

A number of large investors have recently bought and sold shares of TEM. Northwestern University purchased a new position in shares of Tempus AI during the second quarter worth about $491,000. WINTON GROUP Ltd acquired a new position in shares of Tempus AI in the second quarter valued at approximately $634,000. EFG Asset Management North America Corp. purchased a new stake in shares of Tempus AI during the second quarter worth approximately $1,333,000. Pier Capital LLC acquired a new stake in shares of Tempus AI during the second quarter worth $2,301,000. Finally, Allen Operations LLC acquired a new position in Tempus AI in the 2nd quarter valued at $3,831,000.

Tempus AI Stock Down 0.5 %

TEM traded down $0.18 on Friday, hitting $38.75. 336,632 shares of the company’s stock were exchanged, compared to its average volume of 1,227,110. Tempus AI has a fifty-two week low of $22.89 and a fifty-two week high of $47.09.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.